About VAMSI LABS
VAMSI LABS is a Healthcare company based in Solapur (India). It manufactures pharmaceutical ingredients for respiratory, migraine, and psychotic treatments. It operates on a B2B model. Its chief executive, as recorded, is Madana Kesava Reddy. Its Indian entity Vamsi Labs Limited reported revenue of ₹167 Cr. VAMSI LABS offers products and services including Active Pharmaceutical Ingredients, API Intermediates, and Piperidine and Piperidones. Its focus areas include Pharmaceuticals, API Manufacturing, Anti-Migraine Drugs and Anti-Asthmatic Drugs. Its competitors include Viyash, Inventys and Blue Jet Healthcare; 2 of its 3 listed competitors have raised funding.
Company details
Vamsi Labs Ltd. is a major manufacturer of Active Pharmaceutical Ingredients, specializing in anti-asthmatic, anti-migraine, and anti-psychotic APIs. The company operates from its factory in Solapur, Maharashtra, India, using modern technology to minimize environmental impact, including zero discharge practices. It exports products to countries like Vietnam, Singapore, and Brazil, serving global clients through B2B channels and providing technical support.
- Headquarters Solapur, India
- SectorsHealthcare
- Email••••••••
- Website vamsilabs.com
- Legal Name Vamsi Labs Limited
- Date of Incorporation 09 Jan, 1991
- Jurisdiction North Solapur, Maharashtra, India
- Annual Revenue₹167 Cr
FY 2025 · +28% YoY
- Net Profit₹16.00 Cr
FY 2025 · 10% margin
- EBITDA₹37.51 Cr
FY 2025 · 22% margin
Associated legal entities of VAMSI LABS
VAMSI LABS operates through Vamsi Labs Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Vamsi Labs Limited CIN U24231MH1991PLC059750 | Active | 09 Jan 1991 | North Solapur, Maharashtra | ₹167 Cr | 288 | 10 | View details |
Products & Services of VAMSI LABS
VAMSI LABS offers a comprehensive portfolio of products and services, including Active Pharmaceutical Ingredients, API Intermediates, and Piperidine and Piperidones.
Ingredients used in drug production for respiratory treatments.
Intermediate compounds for pharmaceutical manufacturing processes.
Chemical compounds for anti-asthmatic and other drug formulations.
Board of directors of Vamsi Labs Limited (VAMSI LABS)
Vamsi Labs Limited is the primary company behind VAMSI LABS. The board of Vamsi Labs Limited currently have 8 directors; the longest-serving is Keshava Reddy Madana, appointed in 1991. 16 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Keshava Reddy Madana DIN 01916588 | Managing Director | 09 Jan 1991 | 35 yrs 9 mo | Vamsi Labs Limited |
| Jaganmohan Venkata Swamy Anakala DIN 02796369 | Whole-time director | 30 Sep 2010 | 16 yrs 1 mo | Vamsi Labs Limited |
| Priyanka Aravind Nandyala DIN 07489016 | Whole-time director | 21 Apr 2016 | 10 yrs 6 mo | Vamsi Labs Limited |
| Ravindra Nandlal Purohit DIN 06442047 | Director | 24 Aug 2019 | 7 yrs 2 mo | Vamsi Labs Limited |
| Kashinath Revappa Dhole DIN 01076675 | Director | 27 Apr 2023 | 3 yrs 6 mo | Vamsi Labs Limited |
| Vittal Babu Adusumilli DIN 10245595 | Director | 26 Jul 2023 | 3 yrs 3 mo | Vamsi Labs Limited |
| Durga Prasad Vajjha DIN 10275174 | Director | 17 Aug 2023 | 3 yrs 2 mo | Vamsi Labs Limited |
| Ashokkumar Nagesh Katte DIN 09684126 | Director | 16 Mar 2024 | 2 yrs 7 mo | Vamsi Labs Limited |
People of VAMSI LABS
1 people are tracked at VAMSI LABS (1 in leadership).
| Name | Role | Group |
|---|---|---|
| Owner, CEO, Managing Director | Leadership |
Complete people profiles for VAMSI LABS
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of VAMSI LABS
Figures of Vamsi Labs Limited, the primary company behind VAMSI LABS, for FY 2025. Revenue was ₹167 Cr (+28% year on year). Net profit was ₹16.00 Cr (10% margin). EBITDA was ₹37.51 Cr (22% margin). Revenue has grown at a compounded annual rate of +20% over three years and +21% over five years.
- ₹167 CrRevenue · FY 2025 · +28% YoY
- ₹16.00 CrNet profit · 10% margin
- ₹37.51 CrEBITDA · 22% margin
- ₹2.89 CrPaid-up capital
- 288Employees (provident fund records)
- +20%Revenue CAGR, 3 years
- +21%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Vamsi Labs Limited are on its company page.
Detailed financial statements for VAMSI LABS
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of VAMSI LABS
VAMSI LABS has 3 listed competitors in our database, 2 of them funded. They include Viyash, Inventys and Blue Jet Healthcare.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| viyash.com | 2019 | Hyderabad, India | $120.02M | 277 | APIs and intermediates are manufactured by Viyash as a CDMO. | |
| inventys.in | 2005 | Mumbai, India | $64.34M | 219 | Actives, advanced intermediates, and specialty chemicals are custom manufactured. | |
| bluejethealthcare.com | 1969 | Mumbai, India | 476 | CDMO focused on manufacturing, supplier, and development of intermediates & APIs |
Detailed competitors of VAMSI LABS
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of VAMSI LABS
The website of VAMSI LABS (vamsilabs.com) receives about 1.6K visits a month.
- Monthly visits1.6K
▲ 18.5% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Vamsi Labs
Complete news archive for VAMSI LABS
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about VAMSI LABS
VAMSI LABS is headquartered in Solapur, India. It is registered at Solapur, Maharashtra, India.
Madana Kesava Reddy is the CEO of VAMSI LABS, as recorded in our data.
The primary company behind VAMSI LABS, Vamsi Labs Limited, reported revenue of ₹167 Cr for FY 2025, up 28% year on year.
Vamsi Labs Ltd. is a major manufacturer of Active Pharmaceutical Ingredients, specializing in anti-asthmatic, anti-migraine, and anti-psychotic APIs. The company operates from its factory in Solapur, Maharashtra, India, using modern technology to minimize environmental impact, including zero discharge practices. It exports products to countries like Vietnam, Singapore, and Brazil, serving global clients through B2B channels and providing technical support.
VAMSI LABS's top competitors include Inventys, Viyash and Blue Jet Healthcare.
VAMSI LABS offers Active Pharmaceutical Ingredients, API Intermediates, and Piperidine and Piperidones.
VAMSI LABS operates through Vamsi Labs Limited.
The legal entities of VAMSI LABS currently have 10 directors, including Jaganmohan Venkata Swamy Anakala, Vittal Babu Adusumilli, Priyanka Aravind Nandyala and others.